BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33188905)

  • 1. Transition to HBeAg-negative chronic hepatitis B virus infection is associated with reduced cccDNA transcriptional activity.
    Suslov A; Meier MA; Ketterer S; Wang X; Wieland S; Heim MH
    J Hepatol; 2021 Apr; 74(4):794-800. PubMed ID: 33188905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impact.
    Malmström S; Larsson SB; Hannoun C; Lindh M
    PLoS One; 2012; 7(7):e36349. PubMed ID: 22911677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients.
    Laras A; Koskinas J; Dimou E; Kostamena A; Hadziyannis SJ
    Hepatology; 2006 Sep; 44(3):694-702. PubMed ID: 16941694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals.
    Huang H; Wang J; Li W; Chen R; Chen X; Zhang F; Xu D; Lu F
    J Clin Virol; 2018; 99-100():71-78. PubMed ID: 29353073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
    Wang L; Cao X; Wang Z; Gao Y; Deng J; Liu X; Zhuang H
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection.
    Larsson SB; Malmström S; Hannoun C; Norkrans G; Lindh M
    Virol J; 2015 Dec; 12():213. PubMed ID: 26645241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of intrahepatic total HBV DNA, cccDNA and serum HBsAg level in Chronic Hepatitis B patients with undetectable serum HBV DNA during oral antiviral therapy.
    Li J; Sun X; Fang J; Wang C; Han G; Ren W
    Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):635-643. PubMed ID: 28438570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients.
    Singla B; Chakraborti A; Sharma BK; Kapil S; Chawla YK; Arora SK; Das A; Dhiman RK; Duseja A
    Mol Biol Rep; 2014 Jul; 41(7):4689-96. PubMed ID: 24706057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
    Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
    Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of hepatitis B virus intrahepatic covalently closed circular DNA and serum viral markers in treatment-naive patients with acute and chronic HBV infection.
    Li W; Zhao J; Zou Z; Liu Y; Li B; Sun Y; Li X; Liu S; Cai S; Yao W; Xin S; Lu F; Xu D
    PLoS One; 2014; 9(2):e89046. PubMed ID: 24551214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients.
    Volz T; Lutgehetmann M; Wachtler P; Jacob A; Quaas A; Murray JM; Dandri M; Petersen J
    Gastroenterology; 2007 Sep; 133(3):843-52. PubMed ID: 17854594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients.
    Lin LY; Wong VW; Zhou HJ; Chan HY; Gui HL; Guo SM; Wang H; Huang L; Bao SS; Xie Q; Chan HL
    J Med Virol; 2010 Sep; 82(9):1494-500. PubMed ID: 20648602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection.
    Liu Y; Jiang M; Xue J; Yan H; Liang X
    BMC Gastroenterol; 2019 Apr; 19(1):53. PubMed ID: 30991954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
    Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
    J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfection.
    Dezanet LNC; Maylin S; Gabassi A; Rougier H; Miailhes P; Lascoux-Combe C; Chas J; Girard PM; Delaugerre C; Zoulim F; Lacombe K; Boyd A
    AIDS; 2020 Nov; 34(13):1943-1949. PubMed ID: 32773480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses.
    Pollicino T; Raffa G; Santantonio T; Gaeta GB; Iannello G; Alibrandi A; Squadrito G; Cacciola I; Calvi C; Colucci G; Levrero M; Raimondo G
    J Virol; 2011 Jan; 85(1):432-9. PubMed ID: 20962099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B.
    Lai CL; Wong D; Ip P; Kopaniszen M; Seto WK; Fung J; Huang FY; Lee B; Cullaro G; Chong CK; Wu R; Cheng C; Yuen J; Ngai V; Yuen MF
    J Hepatol; 2017 Feb; 66(2):275-281. PubMed ID: 27639844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of circulating HBV RNA expressed from intrahepatic cccDNA in untreated and NUC treated patients with chronic hepatitis B.
    Testoni B; Scholtès C; Plissonnier ML; Paturel A; Berby F; Facchetti F; Villeret F; Degasperi E; Scott B; Hamilton A; Heil M; Lampertico P; Levrero M; Zoulim F
    Gut; 2024 Mar; 73(4):659-667. PubMed ID: 37879886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.